Pharmaceuticals Government Tenders in Hungary

Registration, quality assurance and the shape of a medicines contract

A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.

Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.

The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.

This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.

Who buys pharmaceuticals in Hungary?

GlobalGov holds 208 pharmaceuticals records from 90 distinct buying organisations in Hungary. The most frequent publishers are International buyer (8 records); International buyer (8 records); Bábolna Nemzeti Ménesbirtok (6 records); Debreceni Egyetem (6 records); Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Rendelőintézet (6 records); International buyer (6 records). Between them the 6 largest account for 19% of everything published, so buying here is spread across many separate authorities.

What are pharmaceuticals contracts worth in Hungary?

11 of the 208 records publish a contract value. The median is $700,000 and the largest single published value is $196.0M. By size, 5 between $100k and $1M, 5 between $1M and $10M, 1 above $10M. The remaining 197 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.

How long do bidders get to respond to pharmaceuticals tenders in Hungary?

Across the 84 Hungary pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 34 days. A quarter of them allowed 32 days or fewer and a quarter stayed open for more than 37. Not one of them closed within a fortnight of being published, so the window on this market is consistently workable.

How often are pharmaceuticals tenders published in Hungary?

Hungary publishes about 2 notices a month in this category, 25 in the last twelve months. That is 34% fewer than the 38 published in the twelve months before that. Over the last three years there were 103, spread across 53 separate months of activity since 17 January 2017. December is historically the busiest month. The most recent was published 21 September 2026.

How does Hungary compare with other pharmaceuticals markets?

Among the 41 countries where GlobalGov holds a comparable pharmaceuticals market, Hungary ranks 25th by number of records. The largest is Germany (4,705 records against 208 here). Within Hungary itself, pharmaceuticals is the 18th largest of the 47 procurement categories tracked here.

Where do the Hungary pharmaceuticals records on this page come from?

These 208 records are collected from 1 official source: TED (208). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-12.

Open Pharmaceuticals tenders in Hungary

Showing 1 of the 1 notices open in this category today. Openness uses the same definition as the Hungary market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.

Other procurement categories in Hungary

Pharmaceuticals procurement in other markets